Supernumerary centrioles lead to abnormal mitosis [1, 2] , which in turn promotes tumorigenesis [3, 4] . Thus, centriole duplication must be coordinated with the cell cycle to ensure that the number of centrioles in the cell doubles precisely during each cell cycle [5] . However, in some transformed cells, centrioles undergo multiple rounds of duplication (reduplication) during prolonged interphase [6] [7] [8] . Mechanisms responsible for centriole reduplication are poorly understood. Here, we report that centrioles reduplicate consistently in cancerous and nontransformed human cells during G2 arrests and that this reduplication requires the activity of Polo-like kinase 1 (Plk1). We also find that a cell's ability to reduplicate centrioles during S arrests depends on the presence of activated (Thr210-phosphorylated) Plk1 at the centrosome. In the absence of activated Plk1, nascent procentrioles remain associated with mother centrioles, which prevents centriole reduplication. In contrast, if Plk1(pT210) appears at the centrosome, procentrioles mature, disengage from mother centrioles, and ultimately duplicate. Plk1 activity is not required for the assembly of procentrioles, however. Thus, the role of Plk1 is to coordinate the centriole duplication cycle with the cell cycle. Activation of Plk1 during late S/G2 induces procentriole maturation, and after this point, the centriole cycle can be completed autonomously, even in the absence of cell-cycle progression.
procentrioles can naturally mature into daughter centrioles. If this assumption is correct, then the ability of U2OS cells to reduplicate centrioles is not due to abnormalities intrinsic to the centriole cycle. Instead, the difference between ''reduplicating'' and ''nonreduplicating'' cell types is based on the stringency of the cell-cycle arrest upon HU treatment. A more stringent S phase arrest should prevent centriole reduplication in U2OS cells. Conversely, centrioles should reduplicate in HeLa cells if the cell cycle is arrested during later S or G2.
To test whether centrioles can reduplicate in G2-arrested cells, we used a small-molecule inhibitor, RO-3306 (hereafter RO), that reversibly arrests cells in late G2 by inhibiting the activity of Cdk1 [12] . Immunofluorescence analyses in synchronous cell populations revealed that the number of cells with more than four centrin-GFP spots gradually increased to >60% after w18 hr of G2 arrest (48 hr after shake-off; see Supplemental Experimental Procedures and Figures S2A and S2B). These additional spots also contained polyglutamylated tubulin and were consistently surrounded by clouds of g-tubulin (Figure 1 ), suggesting that they were bona fide centrioles. Importantly, at later time points, most cells contained a mixture of diplosomes and individual centrioles (Figure 1 ), suggesting that centriole amplification occurred via repetitive rounds of centriole disengagement and duplication [7] . Therefore, both U2OS and HeLa cells readily reduplicate centrioles during RO-induced G2 arrests.
It has previously been demonstrated that centrioles can assemble de novo if all preexisting centrioles are removed from the cell. The de novo assembly occurs during S but not during G1 phase [13, 14] . To test whether centrioles can assemble de novo during RO-induced G2 arrest, we used a laser microbeam to ablate all resident centrioles in HeLa cells 28-48 hr after mitotic shake-off (0-18 hr of G2 arrest). In all 26 cases, laser ablation induced formation of multiple centrin-GFP foci that also contained other centriolar and centrosomal proteins ( Figures S2C and S2D ). Therefore, de novo centriole assembly can be initiated during G2 phase.
We also observed centriole reduplication during ROinduced G2 arrests in nontransformed diploid human RPE-1 cells (Figures S2E-S2H ). This result suggests that centriole reduplication upon G2 arrest is a universal phenomenon that is not limited to transformed cells.
Centrioles Do Not Reduplicate in Emi1-Depleted DNA-Reduplicating Cells Our findings suggest that centriole reduplication requires certain activities that normally emerge during G2. In this regard, HU-arrested U2OS and CHO cells that reduplicate centrioles are known to accumulate higher levels of cyclins A and B. In contrast, in HeLa cells, levels of these proteins remain relatively low [15, 16] . This prompted us to investigate whether centriole reduplication occurs in U2OS cells under conditions that prevent progression into G2 and accumulation of mitotic cyclins.
We used small interfering RNA (siRNA) to deplete early mitotic inhibitor 1 (Emi1) in U2OS and HeLa cells. Emi1 is an interphase suppressor of the anaphase-promoting complex/ cyclosome (APC/C) required for proper coordination between DNA duplication and mitosis [17, 18] . In Emi1-depleted cells, APC/C remains active, leading to degradation of cyclins A and B ( Figure S3A ), as well as geminin [19] . In contrast, cyclin E remains stable, and its activity is sufficient to drive DNA synthesis [18] . As a result of Emi1 depletion, the cells enter perpetual DNA reduplication, a state manifested by the increase in the size of the nucleus [18] .
Despite the perpetuate S phase, w90% of either U2OS or HeLa cells depleted of Emi1 (see Supplemental Experimental Procedures) contained just two centrosomes, as revealed by g-tubulin staining (Figure 2A ). Only one prominent centrin spot was consistently found within each g-tubulin cloud ( Figure 2B ). However, the centrin spot was in most cases distorted, manifesting the initial stages of centriole duplication [7] . Furthermore, Sas6, the protein shown to be recruited to the nascent procentrioles [20] , was consistently associated with the centrin spot ( Figure 2B ). Finally, serial-section electron microscopy (EM) analyses of one HeLa and five U2OS cells confirmed that each cell contained only two diplosomes, each comprising one fully grown centriole and a short procentriole ( Figure 2C ).
We also laser ablated all resident centrioles in Emi1-depleted cells 24-27 hr after mitotic shake-off. This treatment resulted in the activation of de novo centriole assembly in all 13 cells studied ( Figure S3B ). Furthermore, selective ablation of procentrioles within diplosomes [7] in Emi1-depleted HeLa cells resulted in the formation of new procentrioles on the same mother centriole ( Figure S3C ). Thus, cytoplasmic conditions in Emi1-depleted cells remain permissive for the assembly of procentrioles, but not for their development into full-sized daughter centrioles. prompted us to seek the molecular pathways responsible for procentriole maturation during late S and G2 phases.
Several cell-cycle regulators have been linked to the ability of cells to reduplicate centrioles during interphase arrest [16, 21, 22] . For example, overexpression of cyclin A induces centriole reduplication in HU-arrested HeLa cells [16] . Depletion of Plk1 by siRNA prevents centriole reduplication in HU-arrested U2OS cells [22] . Both cyclin A and Plk1 accumulate during late S and G2 phases, a fact consistent with their potential role in procentriole maturation. Furthermore, a recent study suggested that Plk1 activity during early mitosis is required for subsequent disengagement of centrioles at the onset of anaphase [23] .
Phosphorylation of Thr210 by Aurora A has been shown to activate Plk1 during late S and G2 phases [24] . Interestingly, T210-phosphorylated Plk1 was detected on the centrosome, although the significance of this observation was not clear [24] . We found pT210-Plk1 to be present at the centrosome in RO-treated, but not in HU-treated or Emi1-depleted, HeLa cells ( Figure 3 ). In contrast, phosphorylated Plk1 was found at the centrosome in RO-treated and HU-treated, but not in Emi1-depleted, U2OS cells, signifying that the presence of pT210-Plk1 on the centrosome strictly correlates with the conditions that allow procentrioles to mature and disengage.
To determine whether active Plk1 is required for procentriole maturation, we employed U2TR, a U2OS-derived cell line engineered to express, upon induction with doxycycline, a constitutively active phosphomimicking mutant (T210D) of human Plk1 [24] . Similar to the wild-type U2OS cells, noninduced U2TR cells did not reduplicate centrioles upon Emi1 depletion ( Figure 4A ). However, induction of Plk1(T210D) expression in Emi1-depleted U2TR cells by 1 mM doxycycline resulted in the rapid accumulation of supernumerary centrosomes ( Figure 4B ). Importantly, doxycycline-induced cells contained a mixture of diplosomes and individual centrioles, indicating that centriole amplification occurred via repetitive rounds of centriole duplication and disengagement. Also, doxycycline-induced expression of constitutively active Plk1 dramatically accelerated centriole reduplication in HU-arrested U2TR cells, a process known to occur via repetitive rounds of duplication and disengagement ( Figure S4A ).
We used immunofluorescence light microscopy (LM) and EM to directly determine whether procentrioles mature upon expression of Plk1(T210D) in Emi1-depleted U2TR cells. In noninduced cells, hPOC5 protein was consistently present on the mother centrioles but was absent from the immature procentrioles. As early as w12 hr after induction of Plk1(T210D) expression by doxycycline, hPOC5 was found on the procentrioles of Emi1-depleted U2TR cells ( Figure 4C ; Figure S4B ). Accumulation of hPOC5 on the procentrioles occurred prior to their disengagement from the mothers and preceded centriole reduplication. We also found that another centriole maturation marker, CEP170 [25] , accumulated at all centrosomes in doxycycline-induced Emi1-depleted U2TR cells ( Figure S4C ). Serial-section EM analysis confirmed that 72 hr after doxycycline induction, Emi1-depleted U2TR cells contained multiple diplosomes and individual daughter centrioles (two cells; data not shown).
Expression of Plk1(T210D) in Emi1-depleted HeLa cells also increased the number of cells with supernumerary centrioles from w5.4% to w19.4% (data not shown). The lower percentage of centriole-reduplicating cells in this experimental system is likely due to cumulative inefficiency of two consecutive rounds of transfection (Emi1 siRNA followed by Plk1 expression plasmid). However, genetic differences between U2OS and HeLa cells cannot be ruled out at this point.
As expected, cyclin A was not detectable in doxycyclineinduced Emi1-depleted U2TR cells that had reduplicated centrioles (data not shown), meaning that centriole maturation and reduplication, under the conditions used, occur without the accumulation of this mitotic cyclin. Although cyclin A was previously implicated in governing centriole duplication [8] , our findings are not completely unexpected, because cyclins A and E likely play redundant roles in centriole duplication (reviewed in [26] ). In fact, a recent study demonstrated that complete ablation of cyclin A does not affect cell proliferation in fibroblasts [27] .
Up to this point, our experiments suggested that expression of active Plk1 triggers procentriole maturation and reduplication during S phase. To determine whether Plk1 activity is required for centriole reduplication during G2 arrests, we used the specific small-molecule inhibitor BI2536 [28] as well as siRNA against Plk1. We found that centriole reduplication in RO-treated HeLa cells did not occur if Plk1 activity had been inhibited by 100 nM BI2536 or if Plk1 was siRNA depleted ( Figure 4D ). Under both conditions, cells remained with two diplosomes for at least 48 hr. Furthermore, BI2536 prevented centriole reduplication in HU-arrested CHO cells ( Figure S4D) is the transition from G1 into S phase, a time when both DNA and centrioles begin to duplicate as a result of activation of cyclin/Cdk2 [9, 29] . A second synchronization point has recently been suggested to exist during M phase, when activation of separase results in separation of chromatids and disengagement of daughter centrioles from their mothers [30] . However, it is clear that centrioles can also disengage via separase-independent mechanisms. In fact, although centriole disengagement is clearly delayed in separase null cells, most diplosomes still manage to break down eventually [23] . Furthermore, centriole disengagement occurs in some, but not all, cell types when the cell cycle is arrested via HU or aphidicolin treatment [6, 7] . Under these conditions, centrioles disengage and reduplicate asynchronously within a single cell, suggesting that the process is regulated by the factors intrinsic to the centrosome [7] . Although several molecular pathways have been implicated in the ability of certain cells to reduplicate centrioles during a prolonged S period [9, 29, 31] , the mechanism of centriole reduplication remains poorly understood. Previous work suggested that centriole reduplication occurs when cells manage to disengage their centrioles during S arrests and raised the question of what molecular mechanism is responsible for the disengagement [7, 32] . The results presented here identify Plk1-mediated maturation of procentrioles into full-size daughter centrioles as the event both necessary and sufficient for centriole disengagement. Importantly, Plk1 activity is not required for the assembly of new centrioles. We propose that Plk1 activity provides an additional synchronization mechanism between the centriole cycle and the cell cycle, ensuring that centrioles do not disengage or reduplicate if progression toward mitosis is delayed. Given that both normal and transformed cells readily reduplicate their centrioles if the cell cycle is arrested after Plk1 is already activated, late-G2 arrests are likely to have severe negative effects on cell proliferation.
Experimental Procedures
Centrin-GFP-expressing HeLa cells have been described previously [7, 33] . U2OS, CHO (both from American Type Culture Collection), and RPE-1 (Clontech) cells were stably transfected with the previously described CenGFP lentivirus [7] . U2TRT210D, an inducible clone of U2OS expressing the T210D phosphomimicking Plk1 mutant [24] , was a kind gift from R.H. Medema (University of Utrecht, The Netherlands). Plk1(T210D) expression was induced with 1 mg/ml doxocycline (Sigma). Cultures were maintained in Dulbecco's modified Eagle's medium (Invitrogen) supplemented with 10% fetal calf serum (Cellgro), 100 U penicillin, and 1 mg/ml streptomycin (GIBCO). Cells were grown in humidified 5% CO 2 atmosphere at 37 C. Details on cell synchronization, drug treatment, siRNA, and immunostaining are provided in Supplemental Experimental Procedures.
Laser Microsurgery and Microscopy
Laser ablations and live-cell imaging were conducted on a custom-built microsurgery workstation detailed elsewhere [7] . Three-dimensional data sets of fixed cells were collected on a DeltaVision workstation and deconvolved with SoftWorX 2.1 software (Applied Precision). Same-cell LM/serial EM analyses were conducted as described previously [7] .
Quantification and Statistics
For centrosome or centriole numbers, histograms present average values of at least three independent experiments, with at least 200 cells counted per experimental condition or time point. Error bars indicate standard error of the mean. Quantification of centriole-associated hPOC5 signal was measured in average-intensity projections of deconvolved 3D data sets. Fluorescence signal was integrated within a 9 3 9 pixel (w0.6 3 0.6 mm) region of interest centered on the centriole and background corrected. A minimum of seven cells were quantified for each experimental condition.
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